Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Contact

Menu

Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Contact

Search

Close

中文

Menu

中文

Our Vision

Home > Company > Our Vision

Our Vision
Company Profile
Management Team
Advisory Panel
Journey & Honors

Menu

Our Vision
Company Profile
Management Team
Advisory Panel
Journey & Honors

We develop new pharmaceutical drugs for the treatment of genitourinary tumors and related diseases

Links

Company
Technology
Pipeline
Collaboration
News
Careers
Contact

News

Asieris Awarded the Top 100 China Innovative Pharmaceutical Enterprises
Asieris Announces First Patient Enrollment in the Global Phase III Clinical Trial for APL-1702
Asieris Announces the Completion of their Series D Round of Financing
Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)
Asieris’ APL-1501 Approved for Phase I Clinical Trial in Australia
Asieris Received China NMPA’s Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)
Asieris Appointed Dr. Susan Wang as Senior Vice President of Global Business Development

Contact

info@asieris.com
USA
201 King of Prussia Rd
Suite 650
Radnor, PA 19087
China
8F Building 56
1000 Jinhai Rd
Pudong, Shanghai

Join Us

Partner with us

Copyright © 2014-2020 Asieris Pharmaceuticals. All Rights Reserved.

TOP